Fibromyalgia is a disease characterised by generalised diffused musculoskeletal pain without organic cause (William Claw). Nowadays, chronical idiopathic pain is regarded as central interference of perception of pain, not taking into account which tissue or organ is befallen by the pain.
Nowadays lots of authors are of the opinion that fibromyalgia is a generalised neurobiological amplification of sensor stimulus. This is supported by the latest results as well as by morphological research.
The validity of these findings is then strengthened by the fact that they respond to the recently formed diagnostic criteria. The criteria are no longer based on somatic check up with the help of fibromyalgia points.
In 2010 results of a multi centric study of 829 people diagnosed with fibromyalgia were published. The main interest of this research was to evaluate the index of musculoskeletal pain and the seriousness of symptoms.
The cure of fibromyalgia happens in two lines - pharmacologic and non-pharmacological. The non-pharmacological line contains various forms of exercise, hydrotherapy, behavioural therapy and psychological treatment.
In the pharmacological line the dominant components are, according to the recommendation of EULAR and EMEA in Europe, antidepressants and antiepileptic medication (namely pregabalin and amitriptyline).